Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fink

Showing results (431-440 of 440) with videos related to

Pageof 44
Sort By:
You have reached the last page of results.This site can display upto 440 results.
Bioorganic & Medicinal Chemistry Letters|April 27, 2020
Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t (RORγt) agonistsLalgudi S Harikrishnan, Patrice Gill, Muthoni G Kamau, et al.
AJNR. American Journal of Neuroradiology|April 29, 2026
PET-guided Assessment of Amyloid Clearance and Outcomes in a Real-World Cohort of Patients with Alzheimer Disease undergoing Anti-Amyloid TherapyJana Ivanidze, Jae Gardella, Ahlanna Olson, et al.
Journal of Medicinal Chemistry|October 14, 2009
Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester (BMS-599626), a selective and orally efficacious inhibitor of human epidermal growth factor receptor 1 and 2 kinasesAshvinikumar V Gavai, Brian E Fink, David J Fairfax, et al.
The Journal of Clinical Investigation|September 11, 2018
Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myelomaAnna Bianchi-Smiraglia, Archis Bagati, Emily E Fink, et al.
Cell Death and Differentiation|February 22, 2018
FOXQ1 controls the induced differentiation of melanocytic cellsArchis Bagati, Anna Bianchi-Smiraglia, Sudha Moparthy, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 20, 2023
Outcomes of patients with pre-existing disability managed by mobile stroke units: A sub-analysis of the BEST-MSU studyBianca O Pirlog, Asha P Jacob, Suja S Rajan, et al.
Nature Genetics|September 17, 2008
MYH9 is associated with nondiabetic end-stage renal disease in African AmericansW H Linda Kao, Michael J Klag, Lucy A Meoni, et al.
Annals of Neurology|October 6, 2023
Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke UnitsBabak B Navi, Ivo Bach, Alexandra L Czap, et al.
Nature Communications|January 31, 2026
Covalent inhibitor design confers activity against both GDP- and GTP-bound forms of KRAS G12CMatthew L Condakes, Zhuo Zhang, Derek B Danahy, et al.
The New England Journal of Medicine|September 8, 2021
Prospective, Multicenter, Controlled Trial of Mobile Stroke UnitsJames C Grotta, Jose-Miguel Yamal, Stephanie A Parker, et al.
Pageof 44

Showing results (431-440 of 440) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 440 results.
Bioorganic & Medicinal Chemistry Letters|April 27, 2020
Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t (RORγt) agonistsLalgudi S Harikrishnan, Patrice Gill, Muthoni G Kamau, et al.
AJNR. American Journal of Neuroradiology|April 29, 2026
PET-guided Assessment of Amyloid Clearance and Outcomes in a Real-World Cohort of Patients with Alzheimer Disease undergoing Anti-Amyloid TherapyJana Ivanidze, Jae Gardella, Ahlanna Olson, et al.
Journal of Medicinal Chemistry|October 14, 2009
Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester (BMS-599626), a selective and orally efficacious inhibitor of human epidermal growth factor receptor 1 and 2 kinasesAshvinikumar V Gavai, Brian E Fink, David J Fairfax, et al.
The Journal of Clinical Investigation|September 11, 2018
Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myelomaAnna Bianchi-Smiraglia, Archis Bagati, Emily E Fink, et al.
Cell Death and Differentiation|February 22, 2018
FOXQ1 controls the induced differentiation of melanocytic cellsArchis Bagati, Anna Bianchi-Smiraglia, Sudha Moparthy, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 20, 2023
Outcomes of patients with pre-existing disability managed by mobile stroke units: A sub-analysis of the BEST-MSU studyBianca O Pirlog, Asha P Jacob, Suja S Rajan, et al.
Nature Genetics|September 17, 2008
MYH9 is associated with nondiabetic end-stage renal disease in African AmericansW H Linda Kao, Michael J Klag, Lucy A Meoni, et al.
Annals of Neurology|October 6, 2023
Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke UnitsBabak B Navi, Ivo Bach, Alexandra L Czap, et al.
Nature Communications|January 31, 2026
Covalent inhibitor design confers activity against both GDP- and GTP-bound forms of KRAS G12CMatthew L Condakes, Zhuo Zhang, Derek B Danahy, et al.
The New England Journal of Medicine|September 8, 2021
Prospective, Multicenter, Controlled Trial of Mobile Stroke UnitsJames C Grotta, Jose-Miguel Yamal, Stephanie A Parker, et al.
Pageof 44